Shares of Fortis Healthcare raised over 5 per cent to a 52-week high on Thursday on recording a 57 per cent jump in consolidated net profit to ₹260.28 crore in the June quarter of FY26.
It reported a profit of ₹166 crore in same quarter previous year. Revenue from operations soared 16.5 per cent to ₹2,166.72 crore in the quarter under review as against ₹1,858.90 crore in the corresponding quarter last year.
Revenue from hospital business stood at ₹1,838 crore, up 18.6 per cent and the operating EBITDA margin was at 22.1 per cent as against 18.5 per cent in Q1FY25, according to a statement from the company.
The company’s net debt, as of June 30, 2025 stood at ₹1,869 crore from ₹308 crore in the previous year.. The increase in debt compared to previous year was primarily due to the funds raised to part-finance the acquisition of the 31.5 per cent PE stake in Agilus Diagnostics and that of ‘Fortis’ brand and trademarks.
“We have witnessed a healthy start to the financial year, as demonstrated in our Q1 earnings for both hospital and diagnostic businesses,” Ashutosh Raghuvanshi, MD and CEO, Fortis Healthcare, said.
“In the diagnostics business, we have witnessed a strong recovery in both revenues and EBITDA margins, which is reflective of the brand building initiatives undertaken over the last few quarters. We expect this growth momentum to continue going forward,” he said
“The recently executed O&M (operation and management) services agreement with Gleneagles India expands company’s geographic footprint and provides an opportunity to leverage combined strengths to optimize operations and enhance efficiencies,” he added.
The acquisition of Shrimann Superspecialty Hospital in Jalandhar, further strengthening presence in Punjab region with around 1,000 beds.
The stock traded 3.78 per cent positive on the BSE at ₹890.15 as at 10.11 am after hitting a 52-week high at ₹904.75 in early trade against the previous close of ₹857.70.
More Like This
Published on August 7, 2025
